US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

WIRED Business: Startups, Cryptocurrency, Tech Culture, and More by WIRED

As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. Learn about your ad choices: dovetail.prx...View more